Form 4: CME Group Director Kathryn Benesh Acquires Shares

Kathryn Benesh, a director at CME Group, acquired 748 shares of Class A Common Stock on June 25, 2024, at a price of $194.1 per share.

Summary

• On June 25, 2024, Kathryn Benesh, a director of CME Group Inc., acquired 748 shares of Class A Common Stock.
• The shares were purchased at a price of $194.1 per share.
• Following the transaction, Benesh directly owns 1,559 shares of CME Group's Class A Common Stock.
• The acquisition was made pursuant to the CME Group Director Stock Plan, as amended and restated.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of a stock transaction. The director's purchase is a mildly positive signal, but not significantly impactful.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

This is a routine disclosure of a director's stock transaction, which is common in publicly traded companies. It provides transparency to investors regarding insider activity.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider activity.
• The director's stock purchase may have a slightly positive impact on shareholder sentiment.

Key Dates